Evidence map›Paper›PMID 17071577›Full record

ArticleThe American journal of pathology2006

Migrating with myosin VI.

Beatrice Knudsen

Abstract readComment
In one paragraph

Article in The American journal of pathology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Highly selective inhibition of myosin motors provides the basis of potential therapeutic application.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  2. Review
  3. Myosin VI contributes to malignant proliferation of human glioma cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2016
    Article
  4. Dynamic exchange of myosin VI on endocytic structures.The Journal of biological chemistry · 2012
    Article
  5. Article
  6. Article
  7. How are the cellular functions of myosin VI regulated within the cell?Biochemical and biophysical research communications · 2008
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Beatrice KnudsenFred Hutchinson Cancer Research Center, Program in Cancer Biology, Division of Public Health Sciences, 1100 Fairview Avenue North, M5-A864, Seattle, WA 98109, USA. bknudsen@fhcrc.org

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI John Kyung Lee · 2002 to 2026
$58.1M
Transmembrane Proteases and Prostate CarcinogenesisP01CA085859 · NCI · UNIVERSITY OF WASHINGTON · PI VESSELLA, ROBERT LOUIS · 2002 to 2013
$21.2M
CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HEIMFELD, SHELLY · 1999 to 2014
$14.9M
REGULATION OF HEMATOPOIESISR01HL062923 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 1998 to 2008
$3.0M
Androgen Signaling in Neoplastic Prostate GrowthR01DK065204 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, PETER S. · 2003 to 2006
$1.5M
NCI NIH HHS CA85859NCI NIH HHS CA97186NCI NIH HHS P01 CA085859NCI NIH HHS P30 CA015704NCI NIH HHS P30CA015704NCI NIH HHS P50 CA097186NHLBI NIH HHS HL62923NHLBI NIH HHS R01 HL062923NIDDK NIH HHS DK56465NIDDK NIH HHS DK65204NIDDK NIH HHS P30 DK056465NIDDK NIH HHS R01 DK065204
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell MovementBiomarkers, TumorGene Expression Regulation, NeoplasticGenes, NeoplasmHumansMaleMyosin Heavy ChainsProstatic NeoplasmsRNA, MessengerBiomarkers, TumorMyosin Heavy Chainsmyosin VIRNA, Messenger

Identifiers

PMID17071577
PMCPMC1780205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.